Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | ACACB | O00763 | 2/20 | 0.37 |
| ▸ | ACACA | Q13085 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | FABP1 | P07148 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | SLC10A2 | Q12908 | 1/20 | 0.34 |
| ▸ | RARB | P10826 | 1/20 | 0.34 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7215727 | 0.94 | KMT2A (0.44) | KMT2AKDM4EALDH1A1GAAACACB | |
| SCHEMBL7222487 | 0.93 | RARB (0.38) | KDM4ELMNAMAPK1SMN1; SMN2RARB | |
| SCHEMBL7218022 | 0.91 | ACACB (0.38) | KMT2AKDM4EALDH1A1GAAACACB | |
| SCHEMBL7218340 | 0.87 | LTA4H (0.40) | KMT2AACACBACACALMNAMAPK1 | |
| SCHEMBL7216601 | 0.87 | RARB (0.37) | KMT2AKDM4EALDH1A1LMNAL3MBTL1 | |
| SCHEMBL7215961 | 0.87 | HRH3 (0.39) | KMT2AKDM4ELMNAL3MBTL1SMN1; SMN2 | |
| SCHEMBL7222573 | 0.86 | POLB (0.38) | KMT2AKDM4EALDH1A1GAALMNA | |
| SCHEMBL7247416 | 0.85 | RARB (0.46) | KDM4ELMNARARB | |
| SCHEMBL7221094 | 0.85 | ACACB (0.42) | KMT2AKDM4EALDH1A1GAAACACB | |
| SCHEMBL7216131 | 0.84 | MAPT (0.36) | KDM4EACACBACACALMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6627651-B1 | Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2003-09-30 | — | — | US | disclosed |
| EP-1182195-A1 | CYCLIC COMPOUNDS AND USES THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2002-02-27 | — | — | EP | disclosed |